Cellular Analytics is founded upon a proprietary microfluidic platform that enables molecular characterization of cancer at the level of single circulating tumour cells. The technology quantitatively detects sensitivity to immune-oncology agents 'on-chip' at both significantly lower sample volumes and at a fraction of the cost.
Member count: 1-10
Investors 1
| Date | Name | Website |
| - | Fight Agai... | facit.ca |